Skingenuity Limited 11367143 false 2024-06-01 2025-11-30 2025-11-30 The principal activity of the company is aesthetic healthcare procedures Digita Accounts Production Advanced 6.30.9574.0 true 11367143 2024-06-01 2025-11-30 11367143 2025-11-30 11367143 core:CurrentFinancialInstruments core:WithinOneYear 2025-11-30 11367143 core:Non-currentFinancialInstruments core:AfterOneYear 2025-11-30 11367143 1 2025-11-30 11367143 bus:Micro-entities 2024-06-01 2025-11-30 11367143 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-11-30 11367143 bus:FilletedAccounts 2024-06-01 2025-11-30 11367143 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-11-30 11367143 bus:RegisteredOffice 2024-06-01 2025-11-30 11367143 bus:Director1 2024-06-01 2025-11-30 11367143 bus:Director2 2024-06-01 2025-11-30 11367143 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-11-30 11367143 countries:EnglandWales 2024-06-01 2025-11-30 11367143 1 2024-06-01 2025-11-30 11367143 1 2024-05-31 11367143 2023-06-01 2024-05-31 11367143 2024-05-31 11367143 core:CurrentFinancialInstruments core:WithinOneYear 2024-05-31 11367143 core:Non-currentFinancialInstruments core:AfterOneYear 2024-05-31 11367143 1 2024-05-31 11367143 1 2023-06-01 2024-05-31 11367143 1 2023-05-31 iso4217:GBP xbrli:pure

Registration number: 11367143

Skingenuity Limited
Unaudited Filleted Financial Statements
for the Period from 1 June 2024 to 30 November 2025

Skingenuity Limited

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 2

Skingenuity Limited

Company Information

Directors | Dr Kirstie Eccles Ms Jacqui Anne Devereau

Registered office | 11 Camomile Court Thornton Bradford West Yorkshire BD13 3NY

Skingenuity Limited

(Registration number: 11367143)
Balance Sheet as at 30 November 2025

| 2025 £ | 2024 £
Fixed assets | - | 1,069
Current assets | 2,073 | 7,908
Creditors: Amounts falling due within one year | (723) | (5,363)
Net current assets | 1,350 | 2,545
Total assets less current liabilities | 1,350 | 3,614
Creditors: Amounts falling due after more than one year | - | (2,450)
Accruals and deferred income | (1,250) | (1,180)
| 100 | (16)
Capital and reserves | 100 | (16)

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
11 Camomile Court
Thornton
Bradford
West Yorkshire
BD13 3NY
United Kingdom

These financial statements were authorised for issue by the Board on 28 January 2026.

2 | Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2 (2024 - 2).

Skingenuity Limited

(Registration number: 11367143)
Balance Sheet as at 30 November 2025

3 | Related party transactions

Transactions with directors

2025 | At 1 June 2024 £ | Repayments by director £ | At 30 November 2025 £
The Directors have received an interest free loan | 7,807 | (7,807) | -

2024 | At 1 June 2023 £ | Advances to director £ | Repayments by director £ | At 31 May 2024 £
The Directors have received an interest free loan | 5,656 | 7,807 | (5,656) | 7,807

For the financial period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 28 January 2026 and signed on its behalf by:

......................................... Dr Kirstie Eccles Director